{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5.3","upperLimit":"18.3","value":"10.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"description":"Patients receive therapeutic angiotensin-(1-7) SC once daily in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Treatment (Antiangiogenesis Therapy)"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Approximately 5 years","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"months"}